Morepen Labs.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE083A01026
NSEID: MOREPENLAB
BSEID: 500288

INR

39.67

0.00 (0.00%)

BSENSE

Dec 17

BSE+NSE Vol: 18.19 lacs

{
  "main_header": {
    "sid": 546345,
    "name": "Morepen Labs.",
    "stock_name": "Morepen Labs.",
    "full_name": "Morepen Laboratories Ltd",
    "name_url": "stocks-analysis/morepen-labs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.67",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "39.67",
    "mcapval": "2,243.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500288,
    "symbol": "MOREPENLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083A01026",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "18.19 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/morepen-labs-546345-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Morepen Labs. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-morepen-labs-fallingrising-3761747",
        "imagepath": "",
        "date": "2025-12-18 01:00:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Morepen Laboratories closed at ₹39.75 on 17 December, down ₹1.15 or 2.81% from the previous close. The stock hit a new 52-week low of ₹39.41 during the day, marking a continuation of a three-day losing streak that has seen the share price decline by 4.29%. This recent weakness contrasts starkly with the broader market, as the Sensex gained 0.20% over the past week, underscoring Morepen Labs’ relative underperformance.</p>\n<p>Over the past month, the stock has declined by 14.02%, significantly worse than the Sensex’s marginal fall of 0.46%. Year-to-date, Morepen Labs has lost 49.23% of its value, while the Sensex has risen by 8.22%. The one-year return is even more telling, with the stock down 53.40% compared to the Sensex’s 4.80% gain...."
      },
      {
        "title": "Morepen Laboratories Stock Falls to 52-Week Low of Rs.40 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-hits-52-week-low-amidst-continued-downtrend-3761430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3761430.png",
        "date": "2025-12-17 14:47:23",
        "description": "Morepen Laboratories has reached a new 52-week low of Rs.40, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market valuation."
      },
      {
        "title": "Morepen Labs. Sees Revision in Market Assessment Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-labs-downgraded-to-strong-sell-amid-weak-financial-and-technical-trends-3759908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLabs_mojoScore_3759908.png",
        "date": "2025-12-16 10:10:19",
        "description": "Morepen Labs., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights subdued financial performance and technical indicators that have influenced the stock’s current market perception."
      },
      {
        "title": "Morepen Laboratories Stock Falls to 52-Week Low of Rs.40.01 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs4001-3753575",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3753575.png",
        "date": "2025-12-09 10:13:26",
        "description": "Morepen Laboratories has reached a new 52-week low of Rs.40.01, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment."
      },
      {
        "title": "Morepen Laboratories Stock Falls to 52-Week Low of Rs.41.33",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs4133-3751174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3751174.png",
        "date": "2025-12-08 10:53:21",
        "description": "Shares of Morepen Laboratories touched a fresh 52-week low of Rs.41.33 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock has been underperforming the Pharmaceuticals & Biotechnology sector and continues to trade below all major moving averages."
      },
      {
        "title": "Morepen Laboratories Stock Hits 52-Week Low at Rs.41.33 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-stock-falls-to-52-week-low-of-rs4133-3751172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MorepenLaborato_priceRelatedfactors_3751172.png",
        "date": "2025-12-08 10:53:16",
        "description": "Morepen Laboratories has reached a new 52-week low of Rs.41.33, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over the past year."
      },
      {
        "title": "Morepen Laboratories Faces Challenging Market Conditions Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3727841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MorepenLaborato_mojoScore_3727841.png",
        "date": "2025-11-25 08:42:08",
        "description": "Morepen Laboratories, a player in the Pharmaceuticals & Biotechnology sector, is currently navigating a complex market environment marked by subdued financial results and cautious technical indicators. Recent shifts in evaluation metrics reflect a nuanced perspective on the company’s quality, valuation, financial trends, and technical outlook, underscoring the challenges it faces amid broader market dynamics."
      },
      {
        "title": "How has been the historical performance of Morepen Labs.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-morepen-labs-3726354",
        "imagepath": "",
        "date": "2025-11-24 23:14:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Morepen Labs’ net sales have shown a consistent upward trend, increasing from ₹768.54 crores in March 2019 to ₹1,811.58 crores in March 2025. This represents a more than twofold increase over six years, reflecting the company’s expanding market presence and product portfolio. Despite a slight dip in sales in March 2022 compared to the previous year, the overall trajectory remains positive.</p>\n<p>Operating profit before depreciation and interest (PBDIT) excluding other income rose from ₹67.52 crores in 2019 to ₹174.07 crores in 2025, indicating improved operational efficiency. Including other income, operating profit increased to ₹192.43 crores in the latest fiscal year. Profit after tax (PAT) also followed a similar pattern, climbing from ₹28.84 cro..."
      },
      {
        "title": "Is Morepen Labs. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-morepen-labs-technically-bullish-or-bearish-3716888",
        "imagepath": "",
        "date": "2025-11-20 08:11:09",
        "description": "As of 19 November 2025, the technical trend for Morepen Labs has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages confirm this bearish outlook. Bollinger Bands are also indicating a bearish trend on both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, indicating some mixed signals. Overall, the Dow Theory supports a mildly bearish view on both weekly and monthly time frames. The stock has underperformed significantly against the Sensex over various periods, further reinforcing the bearish sentiment...."
      }
    ],
    "total": 353,
    "sid": "546345",
    "stock_news_url": "https://www.marketsmojo.com/news/morepen-laboratories-546345"
  },
  "announcements": [
    {
      "details": "Morepen Laboratories Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Morepen Laboratories Limited - Outcome of Board Meeting",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Morepen Laboratories Limited has informed the Exchange regarding 'Order Passed by SEBI'.",
      "source": "NSE",
      "caption": "Morepen Laboratories Limited - Updates",
      "datetime": "25-Sep-2019"
    },
    {
      "details": " <table><tr><td>Morepen Laboratories Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 19, 2019 </td></tr></table>",
      "source": "NSE",
      "caption": "Shareholders meeting",
      "datetime": "24-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Morepen Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Aug 25",
          "dt": "2025-08-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Morepen Labs. falling/rising?

2025-12-18 01:00:46

Recent Price Movement and Market Context

Morepen Laboratories closed at ₹39.75 on 17 December, down ₹1.15 or 2.81% from the previous close. The stock hit a new 52-week low of ₹39.41 during the day, marking a continuation of a three-day losing streak that has seen the share price decline by 4.29%. This recent weakness contrasts starkly with the broader market, as the Sensex gained 0.20% over the past week, underscoring Morepen Labs’ relative underperformance.

Over the past month, the stock has declined by 14.02%, significantly worse than the Sensex’s marginal fall of 0.46%. Year-to-date, Morepen Labs has lost 49.23% of its value, while the Sensex has risen by 8.22%. The one-year return is even more telling, with the stock down 53.40% compared to the Sensex’s 4.80% gain....

Morepen Laboratories Stock Falls to 52-Week Low of Rs.40 Amidst Prolonged Downtrend

2025-12-17 14:47:23

Morepen Laboratories has reached a new 52-week low of Rs.40, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market valuation.

Morepen Labs. Sees Revision in Market Assessment Amidst Challenging Financial Trends

2025-12-16 10:10:19

Morepen Labs., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights subdued financial performance and technical indicators that have influenced the stock’s current market perception.

Morepen Laboratories Stock Falls to 52-Week Low of Rs.40.01 Amidst Prolonged Downtrend

2025-12-09 10:13:26

Morepen Laboratories has reached a new 52-week low of Rs.40.01, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market sentiment.

Morepen Laboratories Stock Falls to 52-Week Low of Rs.41.33

2025-12-08 10:53:21

Shares of Morepen Laboratories touched a fresh 52-week low of Rs.41.33 today, marking a significant decline amid broader market fluctuations and sectoral pressures. The stock has been underperforming the Pharmaceuticals & Biotechnology sector and continues to trade below all major moving averages.

Morepen Laboratories Stock Hits 52-Week Low at Rs.41.33 Amidst Prolonged Downtrend

2025-12-08 10:53:16

Morepen Laboratories has reached a new 52-week low of Rs.41.33, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over the past year.

Morepen Laboratories Faces Challenging Market Conditions Amid Mixed Financial and Technical Signals

2025-11-25 08:42:08

Morepen Laboratories, a player in the Pharmaceuticals & Biotechnology sector, is currently navigating a complex market environment marked by subdued financial results and cautious technical indicators. Recent shifts in evaluation metrics reflect a nuanced perspective on the company’s quality, valuation, financial trends, and technical outlook, underscoring the challenges it faces amid broader market dynamics.

How has been the historical performance of Morepen Labs.?

2025-11-24 23:14:10

Revenue and Profit Growth

Morepen Labs’ net sales have shown a consistent upward trend, increasing from ₹768.54 crores in March 2019 to ₹1,811.58 crores in March 2025. This represents a more than twofold increase over six years, reflecting the company’s expanding market presence and product portfolio. Despite a slight dip in sales in March 2022 compared to the previous year, the overall trajectory remains positive.

Operating profit before depreciation and interest (PBDIT) excluding other income rose from ₹67.52 crores in 2019 to ₹174.07 crores in 2025, indicating improved operational efficiency. Including other income, operating profit increased to ₹192.43 crores in the latest fiscal year. Profit after tax (PAT) also followed a similar pattern, climbing from ₹28.84 cro...

Is Morepen Labs. technically bullish or bearish?

2025-11-20 08:11:09

As of 19 November 2025, the technical trend for Morepen Labs has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages confirm this bearish outlook. Bollinger Bands are also indicating a bearish trend on both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, indicating some mixed signals. Overall, the Dow Theory supports a mildly bearish view on both weekly and monthly time frames. The stock has underperformed significantly against the Sensex over various periods, further reinforcing the bearish sentiment....

View All News